BR0008589A - Composto de tipirano, processo para sua preparação e seu uso - Google Patents
Composto de tipirano, processo para sua preparação e seu usoInfo
- Publication number
- BR0008589A BR0008589A BR0008589-8A BR0008589A BR0008589A BR 0008589 A BR0008589 A BR 0008589A BR 0008589 A BR0008589 A BR 0008589A BR 0008589 A BR0008589 A BR 0008589A
- Authority
- BR
- Brazil
- Prior art keywords
- optionally substituted
- compound
- preparation
- carboxy
- thia
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/46—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom
- C07D333/48—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/02—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
- C07D339/08—Six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Virology (AREA)
- Dermatology (AREA)
- Cardiology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Abstract
"COMPOSTO DE TIPIRANO, PROCESSO PARA SUA PREPARAçãO E SEU USO". Composto da fórmula: onde R^ 1^ é alquila inferior, halogênio, grupo heterocíclico opcionalmente substituído ou arila opcionalmente substituído, R^ 2^ é carboxi, carboxi protegido ou carboxi amidado. Ar é arila opcionalmente substituído ou grupo heterocíclico opcionalmente substituído, A é alquileno inferior, X é oxa ou uma ligação simples, Y é tia, sulfinila ou sulfonila, Z é metileno, tia, sulfinila ou sulfonila, m e n são, cada qual, um número inteiro de 0 a 6, e 1 m + n 6, ou seu sal, que é útil como inibidor de metaloproteinases matrizes (MMP) ou de fator de necrose tumoral <244> (TNF <244>).
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPP8068A AUPP806899A0 (en) | 1999-01-07 | 1999-01-07 | Cyclic compound |
AUPQ1702A AUPQ170299A0 (en) | 1999-07-19 | 1999-07-19 | Cyclic compound |
PCT/JP2000/000018 WO2000040576A2 (en) | 1999-01-07 | 2000-01-06 | Thiopyran compounds as inhibitors of mmp |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0008589A true BR0008589A (pt) | 2002-01-29 |
Family
ID=25645967
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0008589-8A BR0008589A (pt) | 1999-01-07 | 2000-01-06 | Composto de tipirano, processo para sua preparação e seu uso |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1140895B1 (pt) |
JP (1) | JP2002534424A (pt) |
KR (1) | KR20010102968A (pt) |
CN (1) | CN1343206A (pt) |
AR (1) | AR022213A1 (pt) |
AT (1) | ATE262517T1 (pt) |
BR (1) | BR0008589A (pt) |
CA (1) | CA2357874A1 (pt) |
DE (1) | DE60009260T2 (pt) |
ES (1) | ES2213563T3 (pt) |
HK (1) | HK1045312A1 (pt) |
HU (1) | HUP0104859A3 (pt) |
MX (1) | MXPA01006896A (pt) |
RU (1) | RU2221792C2 (pt) |
TR (1) | TR200101936T2 (pt) |
WO (1) | WO2000040576A2 (pt) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPR755501A0 (en) * | 2001-09-07 | 2001-09-27 | Fujisawa Pharmaceutical Co., Ltd. | Cyclic compound |
JP2003081838A (ja) * | 2001-09-11 | 2003-03-19 | Rohto Pharmaceut Co Ltd | グルコサミン製剤 |
WO2003031431A1 (en) * | 2001-10-09 | 2003-04-17 | Bristol-Myers Squibb Company | Cyclic sulfone derivatives as inhibitors of matrix metalloproteinases and/or tnf-$g(a) converting enzyme (tace) |
SE0300092D0 (sv) * | 2003-01-15 | 2003-01-15 | Astrazeneca Ab | Novel compounds |
BRPI0810719A8 (pt) * | 2007-04-30 | 2016-03-08 | Abbott Lab | Inibidores da enzima diacilglicerol o-acetiltansferase tipo 1 |
WO2009096198A1 (ja) * | 2008-02-01 | 2009-08-06 | Pharma Ip Limited Liability Intermediary Corporations | 新規ビアリール誘導体 |
FR2962649A1 (fr) | 2010-07-19 | 2012-01-20 | Conservatoire Nat Arts Et Metiers | Traitement d'une pathologie liee a un effet excessif du tnf par un compose de benzene sulfonamide |
RU2536205C2 (ru) * | 2012-09-27 | 2014-12-20 | Федеральное Государственное Бюджетное Учреждение Науки Институт Нефтехимии И Катализа Ран | Способ получения 5-метоксикарбонил-1,3-дитиана, обладающего фунгицидной активностью |
WO2015028960A1 (en) * | 2013-08-28 | 2015-03-05 | Piramal Enterprises Limited | Substituted heterocyclic derivatives as gpr agonists and uses thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8801300D0 (en) * | 1988-01-21 | 1988-02-17 | May & Baker Ltd | New compositions of matter |
-
2000
- 2000-01-06 JP JP2000592284A patent/JP2002534424A/ja not_active Withdrawn
- 2000-01-06 EP EP00900122A patent/EP1140895B1/en not_active Expired - Lifetime
- 2000-01-06 WO PCT/JP2000/000018 patent/WO2000040576A2/en not_active Application Discontinuation
- 2000-01-06 CA CA002357874A patent/CA2357874A1/en not_active Abandoned
- 2000-01-06 DE DE60009260T patent/DE60009260T2/de not_active Expired - Fee Related
- 2000-01-06 MX MXPA01006896A patent/MXPA01006896A/es unknown
- 2000-01-06 ES ES00900122T patent/ES2213563T3/es not_active Expired - Lifetime
- 2000-01-06 CN CN00804771A patent/CN1343206A/zh active Pending
- 2000-01-06 TR TR2001/01936T patent/TR200101936T2/xx unknown
- 2000-01-06 AR ARP000100043A patent/AR022213A1/es unknown
- 2000-01-06 KR KR1020017008512A patent/KR20010102968A/ko not_active Application Discontinuation
- 2000-01-06 HU HU0104859A patent/HUP0104859A3/hu unknown
- 2000-01-06 BR BR0008589-8A patent/BR0008589A/pt not_active IP Right Cessation
- 2000-01-06 AT AT00900122T patent/ATE262517T1/de not_active IP Right Cessation
- 2000-01-06 RU RU2001121981/04A patent/RU2221792C2/ru not_active IP Right Cessation
-
2002
- 2002-09-25 HK HK02106999.6A patent/HK1045312A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
ATE262517T1 (de) | 2004-04-15 |
HUP0104859A2 (en) | 2002-10-28 |
KR20010102968A (ko) | 2001-11-17 |
HK1045312A1 (zh) | 2002-11-22 |
CN1343206A (zh) | 2002-04-03 |
WO2000040576A2 (en) | 2000-07-13 |
WO2000040576A3 (en) | 2001-03-22 |
DE60009260D1 (de) | 2004-04-29 |
AR022213A1 (es) | 2002-09-04 |
CA2357874A1 (en) | 2000-07-13 |
JP2002534424A (ja) | 2002-10-15 |
EP1140895A2 (en) | 2001-10-10 |
ES2213563T3 (es) | 2004-09-01 |
DE60009260T2 (de) | 2004-08-05 |
RU2221792C2 (ru) | 2004-01-20 |
MXPA01006896A (es) | 2002-06-04 |
TR200101936T2 (tr) | 2001-12-21 |
EP1140895B1 (en) | 2004-03-24 |
HUP0104859A3 (en) | 2002-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200500312A1 (ru) | Новые спироконденсированные хиназолиноны и их применение в качестве ингибиторов фосфодиэстераз | |
EA200700188A1 (ru) | Производные замещенного 2-алкилхиназолинона как ингибиторы parp | |
ATE253545T1 (de) | Biarylessigsäure-derivate und ihre verwendung als cox-2 inhibitoren | |
BR0207865A (pt) | Benzotiadiazinas inibidores de metaloproteinases de matriz | |
EA200401197A1 (ru) | Пиперазинил-, пиперидинил- и морфолинилпроизводные как новые ингибиторы гистондеацетилазы | |
EA200700185A1 (ru) | Производные хиназолиндиона в качестве ингибиторов parp | |
ES2168953A1 (es) | Derivados de oxima y su uso como acidos latentes | |
BR0201697A (pt) | Compostos de alfa-aminoácid0, processo para a sua preparação e composições farmacêuticas contendo os mesmos | |
BRPI0412894A (pt) | tienopiridina e furopiridina inibidores de quinases | |
BR0113989A (pt) | Compostos, composições farmacêuticas, processo para a preparação de uma composição farmacêutica, e, uso de pelo menos um dos compostos | |
EA200200253A1 (ru) | Ингибиторы клеточной адгезии | |
AU2006232435A8 (en) | BCRP/ABCG2 inhibitor | |
EA200201071A1 (ru) | Циклопентилзамещенные производные глутарамида в качестве ингибиторов нейтральной эндопептидазы | |
ATE126509T1 (de) | Disäuren von diarylstyrylchinolin. | |
BR0008589A (pt) | Composto de tipirano, processo para sua preparação e seu uso | |
BR0013074A (pt) | Derivados de ácido hidrox mico substituìdos de arilsulfonamido | |
EA200100809A1 (ru) | 2,3,4,5-тетрагидро-1h-[1,4]бензодиазепин-3-гидроксамовые кислоты как ингибиторы матриксных металлопротеиназ | |
BR9611636A (pt) | Compostos de mercaptoalquilpeptidila que apresentam um substituinte imdazol e seu uso como inibidores de metaloproteinases de matriz (mmp) e/ou como fator de necrose de tumores (tnf). | |
BR0317284A (pt) | Inibidores aminocianopiridina de proteìna quinase-2 ativada com proteìna quinase ativada com mitógeno | |
EA201000612A1 (ru) | Антагонисты cgrp-пептиды | |
EA200100090A2 (ru) | Новые пиперидин-4-сульфонамидные производные, способ их получения и содержащие их фармацевтические композиции | |
BR0108791A (pt) | Composto cìclico, processo para sua preparação, composição farmacêutica, seu uso e embalagem comercial | |
EA200400200A1 (ru) | Молекулярные метки для систем органических растворителей | |
EA200500261A1 (ru) | Новые пролекарства (n-2-пиридил-n-2-гидроксикарбонилэтил)амида 1-метил-2-(4-амидинофениламинометил)бензимидазол-5-илкарбоновой кислоты, их получение и их применение в качестве лекарственных средств | |
EA200970497A1 (ru) | Производные пиррола, их получение и их применение в терапии |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTA A 6A, 7A 8A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1962 DE 12/08/2008. |